CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma

Ho-Shin Gwak, Gi Taek Yee, Chul-Kee Park, Jin Wook Kim, Yong-Kil Hong, Seok-Gu Kang, Jeong Hoon Kim, Ho Jun Seol, Tae-Young Jung, Jong Hee Chang, Heon Yoo, Jeong-Hyun Hwang, Se-Hyuk Kim, Bong Jin Park, Sun-Chul Hwang, Min Su Kim, Seon-Hwan Kim, Eun-Young Kim, Ealmaan Kim, Hae Yu Kim, Young-Cho Ko, Hwan Jung Yun, Ji Hye Youn, Juyoung Kim, Byeongil Lee, Seung Hoon Lee

Journal of Korean Neurosurgical Society. 2013;54(6):489-495. Published online 2013 December 31 DOI: https://doi.org/10.3340/jkns.2013.54.6.489

Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma

Marc C. Chamberlain, Denice D. Tsao-Wei, Susan Groshen

Cancer. 2006;106(1):172-179

Link1 Link2

Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic astrocytoma

Marc C. Chamberlain, Denice D. Wei-Tsao, Deborah T. Blumenthal, Michael J. Glantz

Cancer. 2008;112(9):2038-2045

Link1 Link2

Salvage therapy with lomustine for temozolomide refractory recurrent anaplastic astrocytoma: a retrospective study

Marc C. Chamberlain

Journal of Neuro-Oncology. 2015;122(2):329-338

Link1

Link2 Link3

Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma

Marc C. Chamberlain, Sandra Johnston

Journal of Neuro-Oncology. 2008;91(3):359-367

Link1

Link2 Link3

Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma

Journal of Korean Neurosurgical Society. 2013;54(6):489

Link1

CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendroglioma

Marc C. Chamberlain, Michael J. Glantz

Journal of Neuro-Oncology. 2008;89(2):231-238

Link1

Link2 Link3

Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma

Takamitsu Fujimaki, Hisato Ishii, Akira Matsuno, Hajime Arai, Tadayoshi Nakagomi

World Journal of Surgical Oncology. 2007;5(1):

Link1

Link2 Link3

Temozolomide chemotherapy for oligodendroglial tumors

Herbert B. Newton, Nina A. Paleologos

Oligodendroglioma. 2019;341-351

Link1 Link2

4117 POSTER Intensive Chemotherapy and Temozolomide in Children With Newly Diagnosed Anaplastic Astrocytoma

L.I. Shats, M.B. Belogurova, G.G. Radulesku, O.G. Zheludkova

European Journal of Cancer. 2011;47:S288-S289

Link1 Link2

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma

G. Rao

Yearbook of Neurology and Neurosurgery. 2009;2009:186-187

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Korean Neurosurg Soc has participated in CrossRef Text and Data Mining service since March 1, 2015.